Related Experiment Videos
[Studies of brain stem function in infants with apnea syndrome using acoustically evoked brain stem potentials and
Insights
Infants with sleep apnea syndrome showed delayed brainstem auditory evoked potentials, which normalized after aminophylline treatment. Heart rate variability was also altered in untreated infants with sleep apnea.
Area of Science:
- Neurophysiology
- Pediatric Sleep Medicine
- Autonomic Nervous System Function
Context:
- Investigating neurophysiological and autonomic markers in infants with sleep-related breathing disorders.
- Assessing the impact of sleep apnea syndrome on developing auditory pathways and heart rate regulation in infants.
- Evaluating potential therapeutic interventions for infant sleep apnea.
Purpose:
- To evaluate brainstem auditory evoked potentials (BAEP) and heart rate variability (HRV) in infants with sleep apnea syndrome.
- To determine if aminophylline treatment impacts BAEP and HRV in affected infants.
- To compare neurophysiological and autonomic measures between infants with sleep apnea and a healthy control group.
Summary:
- Combined BAEP and HRV measurements were performed on 26 infants (6 days to 3 years).
- Infants with untreated sleep apnea syndrome exhibited prolonged I to V interpeak latencies on BAEP.
- Aminophylline treatment normalized BAEP latencies in six infants; HRV showed altered patterns in untreated sleep apnea infants compared to controls.
Impact:
- Suggests that sleep apnea syndrome can affect central auditory pathway maturation in infants.
- Highlights the potential of aminophylline as a therapeutic agent for improving neurophysiological function in infant sleep apnea.
- Provides insights into autonomic dysfunction associated with infant sleep apnea, informing clinical management and further research.
Abstract:
Twenty-four infants aged between 6 days and 7 months and 2 infants (16 m and 3 y) were subjects of combined brain-stem auditory evoked potential and heart rate variability measurements. Ten infants had a sleep apnea syndrome and one a Near miss sudden infant death syndrome; thirteen infants formed the control group. Seventeen of the twenty-six infants had normal, age-depended brain stem potentials. All infants of the apnea syndrome-group, which had no therapy, had increased I to V interpeak latencies outside of the one-sigma level, the six infants treated with aminophylline were within the normal range. Heart rate variability measurements revealed the following mean +/- standard deviation of the control group: 4.5% +/- 1.5%; of the apnea syndrome-group without therapy: 5.4% +/- 2.0%.